No Data
Neuren Pharmaceuticals Receives Share of Proceeds From Rare Pediatric Disease Priority Review Voucher Sale
Neuren Pharmaceuticals Limited's (ASX:NEU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
AU Evening Wrap | ASX 200 Climbs with Gains Across All Sectors
Why Did This $1.4 Billion ASX 200 Healthcare Stock Just Dive 9%?
Why CAR Group, Myer, Neuren, and Yancoal Shares Are Falling Today
Neuren Says US Partner Filed Marketing Application for Rett Syndrome Drug Candidate; Shares Fall Near 1.5-Year Low
